| Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag DR Casimiro, F Wang, WA Schleif, X Liang, ZQ Zhang, TW Tobery, ... Journal of virology 79 (24), 15547-15555, 2005 | 312 | 2005 |
| Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations J Zhu, MC Wiener, C Zhang, A Fridman, E Minch, PY Lum, JR Sachs, ... PLoS computational biology 3 (4), e69, 2007 | 256 | 2007 |
| Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-γ agonists DL Gerhold, F Liu, G Jiang, Z Li, J Xu, M Lu, JR Sachs, A Bagchi, ... Endocrinology 143 (6), 2106-2118, 2002 | 237 | 2002 |
| Titrating T‐cell epitopes within self‐assembled vaccines optimizes CD4+ helper T cell and antibody outputs RR Pompano, J Chen, EA Verbus, H Han, A Fridman, T McNeely, ... Advanced healthcare materials 3 (11), 1898-1908, 2014 | 129 | 2014 |
| Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host … TB McNeely, NA Shah, A Fridman, A Joshi, JS Hartzel, RS Keshari, ... Human vaccines & immunotherapeutics 10 (12), 3513-3516, 2014 | 103 | 2014 |
| Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors CM Diaz, A Chiappori, L Aurisicchio, A Bagchi, J Clark, S Dubey, ... Journal of translational medicine 11, 1-13, 2013 | 94 | 2013 |
| Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria JS Armistead, I Morlais, DK Mathias, JG Jardim, J Joy, A Fridman, ... Infection and immunity 82 (2), 818-829, 2014 | 86 | 2014 |
| A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein A Tang, Z Chen, KS Cox, HP Su, C Callahan, A Fridman, L Zhang, ... Nature communications 10 (1), 4153, 2019 | 78 | 2019 |
| Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing X He, S Quan, M Xu, S Rodriguez, SL Goh, J Wei, A Fridman, ... Proceedings of the National Academy of Sciences 118 (15), e2025866118, 2021 | 64 | 2021 |
| Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma A Gavazza, G Lubas, A Fridman, D Peruzzi, JA Impellizeri, L Luberto, ... Human gene therapy 24 (8), 728-738, 2013 | 60 | 2013 |
| Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9 L Aurisicchio, D Peruzzi, A Conforti, S Dharmapuri, A Biondo, S Giampaoli, ... Clinical Cancer Research 15 (5), 1575-1584, 2009 | 55 | 2009 |
| Mixed markov models A Fridman Proceedings of the National Academy of Sciences 100 (14), 8092-8096, 2003 | 49 | 2003 |
| Therapeutic Vaccination Halts Disease Progression in BALB-neuT Mice: The Amplitude of Elicited Immune Response Is Predictive of Vaccine Efficacy B Cipriani, A Fridman, C Bendtsen, S Dharmapuri, C Mennuni, I Pak, ... Human gene therapy 19 (7), 670-680, 2008 | 44 | 2008 |
| An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups VB Pinto, EE Moran, F Cruz, XM Wang, A Fridman, WD Zollinger, ... Vaccine 29 (44), 7752-7758, 2011 | 39 | 2011 |
| High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8+ T-Cell Expansion but Improved Virus Control MP Davenport, L Zhang, A Bagchi, A Fridman, TM Fu, W Schleif, ... Journal of virology 79 (15), 10059-10062, 2005 | 36 | 2005 |
| Categorization versus similarity: The case of container names. SA Sloman, BC Malt, A Fridman Oxford University Press, 2001 | 36 | 2001 |
| Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability L Zhang, E Durr, JD Galli, S Cosmi, PJ Cejas, B Luo, S Touch, P Parmet, ... Vaccine 36 (52), 8119-8130, 2018 | 26 | 2018 |
| Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study L Aurisicchio, A Fridman, D Mauro, R Sheloditna, A Chiappori, A Bagchi, ... Journal of translational medicine 18, 1-8, 2020 | 24 | 2020 |
| Generation and characterization of antibodies specific for caspase-cleaved neo-epitopes: a novel approach X Ai, B Butts, K Vora, W Li, C Tache-Talmadge, A Fridman, H Mehmet Cell death & disease 2 (9), e205-e205, 2011 | 21 | 2011 |
| An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform A Fridman, AC Finnefrock, D Peruzzi, I Pak, N La Monica, A Bagchi, ... Oncoimmunology 1 (8), 1258-1270, 2012 | 19 | 2012 |
